Latest news with #CNBCHalftimeReport
Globe and Mail
20-03-2025
- Business
- Globe and Mail
Markets React to Fed's Forecast Adjustments: E-mini S&P and NQ Face Key Levels
Bill Baruch joined the CNBC Halftime Report from Miami to discuss the market dynamic ahead of the Fed, NVDA's GTC conference, and more. E-mini S&P (June) / E-mini NQ (June) S&P, yesterday's close: Settled at 5729.75, up 60.50 NQ, yesterday's close: Settled at 19,951.00, up 249.25 The Federal Reserve lowered its GDP forecast to 1.7% from 2.1% and raised its Core PCE inflation forecast from 2.5% to 2.7%. The committee also said it will slow the pace of its balance sheet runoff. The adjustments were to be expected and arguably align with an optimistic view because it sees GDP improving and Core PCE coming down in 2026-2027, signaling a temporary hit aligned with tariffs. This, coupled with a calm demeanor from Fed Chair Powell during his press conference, brought calm over markets amid a time of tremendous uncertainties. At least for a moment, there are slightly less uncertainties and risk-assets responded favorably. E-mini S&P and E-mini NQ futures ramped ahead of the Fed's announcement, and after, before coming off the best levels for settlement. The overnight was firm too, but early this morning things turned south. One could blame the traditionally fickle day after the Fed meeting price action, European central bank decisions and jawboning, soft price action in China, and stops below yesterday's late low. The move now creates major three-star resistance, detailed in our levels below, aligning with yesterday's settlement. It also lowers our Pivot and point of balance, a pocket in which we must see price action hold at and above through the first hour in order to set up for strength, otherwise leaving the market vulnerable once again, coming in at…. Want to keep up with the market? Subscribe to our daily Morning Express for essential insights into stocks and equities, including the S&P 500, NASDAQ, and more. Get expert technical analysis, proprietary trading levels, and actionable market bias delivered straight to your inbox. Sign Up for Free Futures Market Research – Blue Line Futures Futures trading involves substantial risk of loss and may not be suitable for all investors. Therefore, carefully consider whether such trading is suitable for you in light of your financial condition. Trading advice is based on information taken from trade and statistical services and other sources Blue Line Futures, LLC believes are reliable. We do not guarantee that such information is accurate or complete and it should not be relied upon as such. Trading advice reflects our good faith judgment at a specific time and is subject to change without notice. There is no guarantee that the advice we give will result in profitable trades. All trading decisions will be made by the account holder. Past performance is not necessarily indicative of future results. Blue Line Futures is a member of NFA and is subject to NFA's regulatory oversight and examinations. However, you should be aware that the NFA does not have regulatory oversight authority over underlying or spot virtual currency products or transactions or virtual currency exchanges, custodians or markets. Therefore, carefully consider whether such trading is suitable for you considering your financial condition. With Cyber-attacks on the rise, attacking firms in the healthcare, financial, energy and other state and global sectors, Blue Line Futures wants you to be safe! Blue Line Futures will never contact you via a third party application. Blue Line Futures employees use only firm authorized email addresses and phone numbers. If you are contacted by any person and want to confirm identity please reach out to us at info@ or call us at 312- 278-0500 Performance Disclaimer Hypothetical performance results have many inherent limitations, some of which are described below. No representation is being made that any account will or is likely to achieve profits or losses similar to those shown. In fact, there are frequently sharp differences between hypothetical performance results and the actual results subsequently achieved by any particular trading program. One of the limitations of hypothetical performance results is that they are generally prepared with the benefit of hindsight. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk in actual trading. For example, the ability to withstand losses or to adhere to a particular trading program in spite of trading losses are material points which can also adversely affect actual trading results. There are numerous other factors related to the markets in general or to the implementation of any specific trading program which cannot be fully accounted for in the preparation of hypothetical performance results and all of which can adversely affect actual trading results. This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
Globe and Mail
27-02-2025
- Business
- Globe and Mail
E-mini S&P and NQ Seek Strength Post-NVDA, Eyeing Key Resistance Levels
Tuesday, amid market panic, Bill Baruch joined the CNBC Halftime Report with his latest moves, adding Palantir and increasing Broadcom and Crowdstrike. S&P, yesterday's close: Settled at 5970.00, down 0.75 NQ, yesterday's close: Settled at 21,187.00, up 38.00 E-mini S&P and E-mini NQ futures are trying to cling to gains ahead of the opening bell amid a deluge of news. NVDA topped earnings expectations yesterday, helping to lift things overnight, but margins and Blackwell timing watered down the reaction. The first revision of Q4 GDP was in line with expectations at 2.3%, but the Price Index was higher at 2.4% versus 2.2%, as was Core PCE Prices for Q4 at 2.7% versus 2.5%. Additionally, Initial Jobless Claims came in higher at 242k versus 222k expected. President Trump then posted on Truth Social that tariffs on Mexico and Canada are on for March 4 th, along with the additional 10% on China. He cited, 'Drugs are still pouring into our Country from Mexico and Canada at very high and unacceptable levels.' Yesterday's midday failure was certainly a disappointment, but on the positive side, that midday high and ensuring low were each higher than that from the prior session; the market is building out a solid market profile of support. Given early buoyancy we must see construction at and above our Pivot and point of balance detailed in the levels below. From there, we must see a range extension to the upside in order to set the stage for a strong finish to the week, this starts with clearing major three-star resistance in the E-mini at… Want to keep up with the market? Subscribe to our daily Morning Express for essential insights into stocks and equities, including the S&P 500, NASDAQ, and more. Get expert technical analysis, proprietary trading levels, and actionable market bias delivered straight to your inbox. Sign Up Futures trading involves substantial risk of loss and may not be suitable for all investors. Therefore, carefully consider whether such trading is suitable for you in light of your financial condition. Trading advice is based on information taken from trade and statistical services and other sources Blue Line Futures, LLC believes are reliable. We do not guarantee that such information is accurate or complete and it should not be relied upon as such. Trading advice reflects our good faith judgment at a specific time and is subject to change without notice. There is no guarantee that the advice we give will result in profitable trades. All trading decisions will be made by the account holder. Past performance is not necessarily indicative of future results. Blue Line Futures is a member of NFA and is subject to NFA's regulatory oversight and examinations. However, you should be aware that the NFA does not have regulatory oversight authority over underlying or spot virtual currency products or transactions or virtual currency exchanges, custodians or markets. Therefore, carefully consider whether such trading is suitable for you considering your financial condition. With Cyber-attacks on the rise, attacking firms in the healthcare, financial, energy and other state and global sectors, Blue Line Futures wants you to be safe! Blue Line Futures will never contact you via a third party application. Blue Line Futures employees use only firm authorized email addresses and phone numbers. If you are contacted by any person and want to confirm identity please reach out to us at info@ or call us at 312- 278-0500 Performance Disclaimer Hypothetical performance results have many inherent limitations, some of which are described below. No representation is being made that any account will or is likely to achieve profits or losses similar to those shown. In fact, there are frequently sharp differences between hypothetical performance results and the actual results subsequently achieved by any particular trading program. One of the limitations of hypothetical performance results is that they are generally prepared with the benefit of hindsight. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk in actual trading. For example, the ability to withstand losses or to adhere to a particular trading program in spite of trading losses are material points which can also adversely affect actual trading results. There are numerous other factors related to the markets in general or to the implementation of any specific trading program which cannot be fully accounted for in the preparation of hypothetical performance results and all of which can adversely affect actual trading results.
Globe and Mail
14-02-2025
- Business
- Globe and Mail
Inflation Resurgence to Big Tech
Inflation is making waves, and Big Tech is feeling the heat. Bill Baruch breaks it all down on CNBC—don't miss his market insights! E-mini S&P (March) / E-mini NQ (March) S&P, yesterday's close: Settled at 6135.25, up 62.50 NQ, yesterday's close: Settled at 22,113.25, up 308.50 E-mini S&P and E-mini NQ futures have shaken off hot inflation data and looming tariffs to close at three-week and two-month highs, respectively. Ironically, the E-mini NQ is the first index to clear the Thursday January 23 rd settlement, when DeepSeek began weighing on price action Friday and before the fallout that Sunday night. I joined the CNBC Halftime Report yesterday and discussed a unique balance between fiscal and monetary policy acting as a tailwind, which can be seen in the video above. Retail Sales this morning came in below expectations with Core -0.4% m/m versus +0.3% expected and headline -0.9% m/m versus -0.2% expected. Although Import Prices came in lower than expected at +0.3% m/m versus +0.4% expected, Export Prices surged by 1.3% versus +0.3%. The E-mini NQ closed above significant resistance at the 21,911-21,968 level, which has now been adjusted and will act as support. However, the E-mini S&P still has not decisively cleared its rare major four-star level at 6133.25-6135.25. As today unfolds, we will look for price action to respond to first key support and overall be constructively buoyed by our pivot and point of balance upon a pullback, coming in at… Want to keep up with the market? Subscribe to our daily Morning Express for essential insights into stocks and equities, including the S&P 500, NASDAQ, and more. Get expert technical analysis, proprietary trading levels, and actionable market bias delivered straight to your inbox. Sign Up Futures trading involves substantial risk of loss and may not be suitable for all investors. Therefore, carefully consider whether such trading is suitable for you in light of your financial condition. Trading advice is based on information taken from trade and statistical services and other sources Blue Line Futures, LLC believes are reliable. We do not guarantee that such information is accurate or complete and it should not be relied upon as such. Trading advice reflects our good faith judgment at a specific time and is subject to change without notice. There is no guarantee that the advice we give will result in profitable trades. All trading decisions will be made by the account holder. Past performance is not necessarily indicative of future results. Blue Line Futures is a member of NFA and is subject to NFA's regulatory oversight and examinations. However, you should be aware that the NFA does not have regulatory oversight authority over underlying or spot virtual currency products or transactions or virtual currency exchanges, custodians or markets. Therefore, carefully consider whether such trading is suitable for you considering your financial condition. With Cyber-attacks on the rise, attacking firms in the healthcare, financial, energy and other state and global sectors, Blue Line Futures wants you to be safe! Blue Line Futures will never contact you via a third party application. Blue Line Futures employees use only firm authorized email addresses and phone numbers. If you are contacted by any person and want to confirm identity please reach out to us at info@ or call us at 312- 278-0500 Performance Disclaimer Hypothetical performance results have many inherent limitations, some of which are described below. No representation is being made that any account will or is likely to achieve profits or losses similar to those shown. In fact, there are frequently sharp differences between hypothetical performance results and the actual results subsequently achieved by any particular trading program. One of the limitations of hypothetical performance results is that they are generally prepared with the benefit of hindsight. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk in actual trading. For example, the ability to withstand losses or to adhere to a particular trading program in spite of trading losses are material points which can also adversely affect actual trading results. There are numerous other factors related to the markets in general or to the implementation of any specific trading program which cannot be fully accounted for in the preparation of hypothetical performance results and all of which can adversely affect actual trading results.
Yahoo
10-02-2025
- Business
- Yahoo
Is Siemens Aktiengesellschaft (SIE.DE) The Best Annual Dividend Stock To Buy Now?
We recently published a list of . In this article, we are going to take a look at where Siemens Aktiengesellschaft (XETRA: stands against other best annual dividend stocks to buy now. In 2025, dividends in MSCI Europe are expected to reach a record high. According to Allianz Global Investors, these firms are likely to increase dividend payouts by 4% year-over-year to €459 billion, up from €440 billion in 2024. In 2026, MSCI Europe dividends could catapult even higher to €496 billion. In Germany alone, payouts are projected to rise from €57 billion in 2024 to €63 billion in 2025, and possibly hit €70 billion in 2026. Allianz Global expects the Tech and Healthcare sectors to offer the highest dividend increases in 2025, while the Energy sector could likely create some weakness. The Financials sector will remain the biggest dividend contributor in Europe. Dividend yields are staying ahead of long-term German government bond yields as well, with the MSCI Europe dividend yield expected to be 3.5% this year. Over the last 40 years, about 39% of MSCI Europe's total annualized return resulted from dividends. Comparatively, dividend payouts made up 22% of total returns in MSCI North America and just over 41% in MSCI Pacific. Jenny Harrington, CNBC Halftime Report's go-to expert on dividends, observed that the broader market's dividends have grown about 5.7% in the last 50-60 years, which means that dividend income is outpacing inflation. She also noted that dividends are a tax-advantaged income stream, which is a huge plus. Harrington also commented that dividend investors are more likely to hold their portfolios rather than selling in a panic when markets go down. They are reluctant to give up their income streams and risk wasting years of effort, which helps keep dividend portfolios steady and resilient, even during market selloffs. Harrington also told investors that some companies may not have strong growth potential but generate high free cash flow, allowing them to pay dividends. However, those seeking high-growth stocks should carefully balance their portfolios. Harrington advised investors to explore opportunities beyond the broader market, as the index is heavily dominated by its top 10 stocks. She suggested that looking at other companies, including dividend stocks, could offer better value and growth potential. Given this, we will now take a look at some of the best annual dividend stocks. For this article, we manually researched annual reports and company websites to see which stocks pay dividends annually. We focused on picking stocks with a consistent record of paying dividends, offering dividend growth, and being financially stable to steer clear of yield traps. The list below is ranked in the ascending order of dividend yield as of February 6. At Insider Monkey, we are obsessed with the stocks that hedge funds pile into. The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points () Dividend Yield as of February 6: 2.51% Number of Hedge Fund Holders: N/A Siemens Aktiengesellschaft (XETRA: headquartered in Munich, Germany, is a global technology company that operates through five main segments – Digital Industries, Smart Infrastructure, Mobility, Siemens Healthineers, and Siemens Financial Services. The company provides automation systems, industrial software, AI-driven solutions for factories and production lines, energy-efficient buildings, renewable energy solutions, rail transport and infrastructure, medical imaging devices, diagnostic tools, and investment, leasing, and financing solutions. On February 5, Siemens Mobility received its first order for Vectron locomotives with battery modules, allowing them to operate short distances without overhead power lines. This eco-friendly innovation reduces emissions and improves logistics efficiency. JeMyn AG, affiliated with Widmer Rail Services, is the client who ordered the Vectron locomotives with battery modules, with delivery set for 2027. The battery module enables efficient shunting operations without additional locomotives, resulting in cost efficiency and sustainability. 2024 was a strong financial year for Siemens Aktiengesellschaft (XETRA: supported by high demand for electrification, transportation, and industrial software. Although automation faced challenges in 2024, Siemens delivered record profits for the year. The company also acquired Altair for $10 billion in October 2024, with the intention of strengthening its position in industrial software and AI. Additionally, Siemens completed the sale of Innomotics, securing a €2.0 billion gain to be reflected in fiscal 2025. For fiscal 2024, Siemens Aktiengesellschaft (XETRA: reported €9.5 billion in free cash flow. The company aims to follow a disciplined capital allocation strategy, focusing on targeted investments for profitable growth. Siemens raised its dividend to €5.20 per share from €4.70 in 2023, offering a 2.5% dividend yield. It is one of the best dividend stocks, ranking 7th on our list. Overall, ranks 7th on our list of best annual dividend stocks to buy now. Overall, ranks first on our list of the best annual dividend stocks. While we acknowledge the potential of to grow, our conviction lies in the belief that certain AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than but that trades at less than 5 times its earnings, check out our report about the . READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
10-02-2025
- Business
- Yahoo
Is Roche Holding AG (RHHBY) The Best Annual Dividend Stock To Buy Now?
We recently published a list of . In this article, we are going to take a look at where Roche Holding AG (OTC:RHHBY) stands against other best annual dividend stocks to buy now. In 2025, dividends in MSCI Europe are expected to reach a record high. According to Allianz Global Investors, these firms are likely to increase dividend payouts by 4% year-over-year to €459 billion, up from €440 billion in 2024. In 2026, MSCI Europe dividends could catapult even higher to €496 billion. In Germany alone, payouts are projected to rise from €57 billion in 2024 to €63 billion in 2025, and possibly hit €70 billion in 2026. Allianz Global expects the Tech and Healthcare sectors to offer the highest dividend increases in 2025, while the Energy sector could likely create some weakness. The Financials sector will remain the biggest dividend contributor in Europe. Dividend yields are staying ahead of long-term German government bond yields as well, with the MSCI Europe dividend yield expected to be 3.5% this year. Over the last 40 years, about 39% of MSCI Europe's total annualized return resulted from dividends. Comparatively, dividend payouts made up 22% of total returns in MSCI North America and just over 41% in MSCI Pacific. Jenny Harrington, CNBC Halftime Report's go-to expert on dividends, observed that the broader market's dividends have grown about 5.7% in the last 50-60 years, which means that dividend income is outpacing inflation. She also noted that dividends are a tax-advantaged income stream, which is a huge plus. Harrington also commented that dividend investors are more likely to hold their portfolios rather than selling in a panic when markets go down. They are reluctant to give up their income streams and risk wasting years of effort, which helps keep dividend portfolios steady and resilient, even during market selloffs. Harrington also told investors that some companies may not have strong growth potential but generate high free cash flow, allowing them to pay dividends. However, those seeking high-growth stocks should carefully balance their portfolios. Harrington advised investors to explore opportunities beyond the broader market, as the index is heavily dominated by its top 10 stocks. She suggested that looking at other companies, including dividend stocks, could offer better value and growth potential. Given this, we will now take a look at some of the best annual dividend stocks. For this article, we manually researched annual reports and company websites to see which stocks pay dividends annually. We focused on picking stocks with a consistent record of paying dividends, offering dividend growth, and being financially stable to steer clear of yield traps. The list below is ranked in the ascending order of dividend yield as of February 6. At Insider Monkey, we are obsessed with the stocks that hedge funds pile into. The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points () A scientist in a lab coat inspecting a flowchart on a computer monitor to diagnose and treat cardiovascular diseases. Dividend Yield as of February 6: 3.33% Number of Hedge Fund Holders: N/A Roche Holding AG (OTC:RHHBY) was established in 1896 and is headquartered in Basel, Switzerland. The company develops treatments for cancer, autoimmune diseases, neurological disorders, respiratory conditions, and more. The company also offers in-vitro diagnostic tests, medical instruments, and digital health solutions for diseases like cancer, diabetes, and COVID-19. On February 7, Roche's phase III REGENCY trial found that Gazyva/Gazyvaro significantly improved renal response in lupus nephritis patients, with 46.4% achieving complete renal response (CRR) vs. 33.1% on standard therapy. The drug also reduced inflammation markers, potentially preserving kidney function. Gazyva/Gazyvaro is the first anti-CD20 monoclonal antibody in a phase III study to show CRR benefits, as published in the New England Journal of Medicine. In 2024, Roche Holding AG (OTC:RHHBY)'s sales grew by 7% to CHF 60.5 billion. There was solid momentum across the Pharmaceuticals and Diagnostics divisions, which made up for the decline in COVID-related sales of CHF 1.1 billion. Roche's core operating profit surged 14%, driven by higher sales, better margins, and cost efficiency. On top of that, operating free cash flow surged 34% to CHF 20.1 billion, giving Roche a strong financial position for future investments. Looking ahead, Roche expects mid-single-digit sales growth in 2025 and aims to increase its dividend for the 38th consecutive year to CHF 9.70. It is one of the best dividend stocks to consider for an income portfolio. Overall, RHHBY ranks 6th on our list of best annual dividend stocks to buy now. Overall, RHHBY ranks first on our list of the best annual dividend stocks. While we acknowledge the potential of to grow, our conviction lies in the belief that certain AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than RHHBY but that trades at less than 5 times its earnings, check out our report about the . READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap Disclosure: None. This article is originally published at Insider Monkey.
